Download

Download eBook for Free

Full Document

FormatFile SizeNotes
PDF file 0.8 MB

Use Adobe Acrobat Reader version 7.0 or higher for the best experience.

Summary Only

FormatFile SizeNotes
PDF file 0.2 MB

Use Adobe Acrobat Reader version 7.0 or higher for the best experience.

Purchase

Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback124 pages $20.00 $16.00 20% Web Discount

Abstract

Each year, substance abuse treatment programs in the United States record approximately 150,000 admissions of youths under the age of 18. Nevertheless, little is known about the effectiveness of the types of community-based services typically available to youths and their families. Researchers interviewed youths treated in 11 adolescent programs that had been identified as having suggestive evidence of effectiveness, in order to learn whether they had better outcomes a year after treatment admission than they would have had at other facilities. The study failed to find strong and persuasive evidence of greater treatment effectiveness at the facilities studied. Relative effectiveness may be difficult to measure because facilities serve different populations, because the study examined relative rather than absolute treatment effects, or because large and significant treatment effects might exist for each evaluated treatment program but might be no longer detectable a year after admission. However, there were consistently small positive effects for direct measures of substance use.

Table of Contents

  • Chapter One

    Introduction

  • Chapter Two

    The ATM Programs

  • Chapter Three

    Case-Mix Adjustment Approach

  • Chapter Four

    Study Procedures

  • Chapter Five

    Case-Mix Adjusted Comparison Samples

  • Chapter Six

    Outcomes

  • Chapter Seven

    Discussion

  • Appendix

    Supporting Tables

The research described in this report was prepared for the Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment and was carried out under the auspices of the RAND Drug Policy Research Center, a joint endeavor of RAND Infrastructure, Safety, and Environment (ISE) and RAND Health.

This report is part of the RAND Corporation technical report series. RAND technical reports may include research findings on a specific topic that is limited in scope or intended for a narrow audience; present discussions of the methodology employed in research; provide literature reviews, survey instruments, modeling exercises, guidelines for practitioners and research professionals, and supporting documentation; or deliver preliminary findings. All RAND reports undergo rigorous peer review to ensure that they meet high standards for research quality and objectivity.

Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.